B6N;129P2-Nox4tm1.2Hwsc/Orl

Status

Available to order

EMMA IDEM:11551
Citation informationRRID:IMSR_EM:11551 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6N;129P2-Nox4tm1.2Hwsc/Orl
Alternative nameC57Bl/6N-Nox4tm1.2Hwsc
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolNox4tm1.2Hwsc
Gene/Transgene symbolNox4

Information from provider

ProviderHarald Schmidt
Provider affiliationDepartment of Pharmacology & Personalised Medicine, Maastricht University
Genetic informationThe Nox4 gene is flanked by loxP sites around exons 14 and 15; cre-loxP technology, type 1 mutation for conditional knock-outs.
Phenotypic informationHomozygous:
No spontaneous phenotype.

Heterozygous:
Not applicable.
Breeding historyRecombinant ES-cell clones were injected into wild-type (C57BL/6) blastocysts. Successfully transfected embryos were then transferred into the uterus of mock-pregnant mice. The resulting chimeras were then mated with C57BL/6 females and the F1 offspring tested for heterozygosity. F1 males were mated with two C57BL/6 females each. Of the resulting offspring 10 males were genotyped by microsatellite analysis of 110 different polymorphic markers (Charles River MAX-BAXSM analysis). Males showing the highest homology to the wild-type C57BL/6 strain were then mated again. After the content of recipient C57BL/6 genome was highest than 95%, the mice were intercrossed to gain homozygous offspring.
References
  • NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.;Casas Ana I, Geuss Eva, Kleikers Pamela W M, Mencl Stine, Herrmann Alexander M, Buendia Izaskun, Egea Javier, Meuth Sven G, Lopez Manuela G, Kleinschnitz Christoph, Schmidt Harald H H W, ;2017;Proceedings of the National Academy of Sciences of the United States of America;114;12315-12320; 29087944
  • Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.;Kleinschnitz Christoph, Grund Henrike, Wingler Kirstin, Armitage Melanie E, Jones Emma, Mittal Manish, Barit David, Schwarz Tobias, Geis Christian, Kraft Peter, Barthel Konstanze, Schuhmann Michael K, Herrmann Alexander M, Meuth Sven G, Stoll Guido, Meurer Sabine, Schrewe Anja, Becker Lore, Gailus-Durner Valérie, Fuchs Helmut, Klopstock Thomas, de Angelis Martin Hrabé, Jandeleit-Dahm Karin, Shah Ajay M, Weissmann Norbert, Schmidt Harald H H W, ;2010;PLoS biology;8;; 20877715
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requirednot known
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous C57BL/6N males, heterozygous C57BL/6N females
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal lymph node morphology / IMPC
  • increased circulating creatinine level / IMPC
  • enlarged lymph nodes / IMPC
  • increased mean corpuscular volume / IMPC
MGI phenotypes (gene matching)
  • abnormal lung morphology / MGI
  • cardiac hypertrophy / MGI
  • abnormal kidney physiology / MGI
  • no phenotypic analysis / MGI
  • abnormal redox activity / MGI
  • decreased neuron apoptosis / MGI
  • oxidative stress / MGI
  • increased response of heart to induced stress / MGI
  • dilated heart / MGI
  • abnormal blood-brain barrier function / MGI
  • cardiovascular system phenotype / MGI
  • cardiac interstitial fibrosis / MGI
  • decreased apoptosis / MGI
  • decreased cerebral infarction size / MGI
  • decreased susceptibility to ischemic brain injury / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • decreased susceptibility to weight loss / MGI

Literature references

  • NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.;Casas Ana I, Geuss Eva, Kleikers Pamela W M, Mencl Stine, Herrmann Alexander M, Buendia Izaskun, Egea Javier, Meuth Sven G, Lopez Manuela G, Kleinschnitz Christoph, Schmidt Harald H H W, ;2017;Proceedings of the National Academy of Sciences of the United States of America;114;12315-12320; 29087944
  • Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.;Kleinschnitz Christoph, Grund Henrike, Wingler Kirstin, Armitage Melanie E, Jones Emma, Mittal Manish, Barit David, Schwarz Tobias, Geis Christian, Kraft Peter, Barthel Konstanze, Schuhmann Michael K, Herrmann Alexander M, Meuth Sven G, Stoll Guido, Meurer Sabine, Schrewe Anja, Becker Lore, Gailus-Durner Valérie, Fuchs Helmut, Klopstock Thomas, de Angelis Martin Hrabé, Jandeleit-Dahm Karin, Shah Ajay M, Weissmann Norbert, Schmidt Harald H H W, ;2010;PLoS biology;8;; 20877715

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).